Put companies on watchlist
VERBIO Vereinigte BioEnergie AG
ISIN: DE000A0JL9W6
WKN: A0JL9W
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

VERBIO Vereinigte BioEnergie AG · ISIN: DE000A0JL9W6 · EQS - adhoc news (50 News)
Country: Germany · Primary market: Germany · EQS NID: 1619425
27 April 2023 04:12PM

VERBIO Vereinigte BioEnergie AG: VERBIO adjusts its forecast for the full financial year 2022/2023 and announces its preliminary EBITDA for the first nine months of the financial year


EQS-Ad-hoc: VERBIO Vereinigte BioEnergie AG / Key word(s): Change in Forecast
VERBIO Vereinigte BioEnergie AG: VERBIO adjusts its forecast for the full financial year 2022/2023 and announces its preliminary EBITDA for the first nine months of the financial year

27-Apr-2023 / 16:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


VERBIO adjusts its forecast for the full financial year 2022/2023 and announces its preliminary EBITDA for the first nine months of the financial year

Zörbig/Leipzig, April 27, 2023 – On the basis of current sales and raw material price levels the original EBITDA expectations for the full financial year 2022/2023 of approximately EUR 300 million are too ambitious. The Management Board is amending the forecast and now expects an EBITDA of approximately EUR 240 million. In the biodiesel segment in particular, the continuing decline in selling prices combined with comparatively expensive vegetable oil purchases due to the time lag between purchases and sales is having a negative impact on earnings.

Due to amended expectations concerning investments and working capital, the Management Board plans net financial assets by the end of the financial year of around EUR 80 million. Prior to this the Company had assumed net financial assets in the order of EUR 30 million at the end of the 2022/2023 financial year.

Based on preliminary calculations Verbio has generated an EBITDA of approximately EUR 214 million in the first nine months of the current financial year 2022/2023.

Detailed information on business developments in the first nine months of the 2022/2023 financial year is provided in the quarterly statement for the period ended March 31, 2023, which will be published on May 11, 2023.

 

Information about VERBIO Vereinigte BioEnergie AG (VERBIO)

VERBIO AG is one of the leading independent bioenergy manufacturers, and is also the only large-scale producer of biodiesel, bioethanol and biomethane in Europe. The Group has approximately 1,000 employees at its locations in Saxony, Saxony-Anhalt and Brandenburg as well as at its foreign subsidiaries in India, the USA, Canada, Poland and Hungary. VERBIO concentrates on the use of internally developed innovative technologies and efficient energy-saving production processes. VERBIO’s biofuels achieve CO2 savings of up to 90 percent compared to petrol or diesel. The Group’s annual production capacity amounts to approximately 660,000 tonnes of biodiesel, 300,000 tonnes of bioethanol and 1,300 gigawatt hours of biomethane. In addition, VERBIO manufactures biofertiliser and animal feed for agricultural use as well as high-value raw materials for the pharmaceutical, cosmetic and foodstuff industries. With its innovative processes and highly efficient production plants, VERBIO is a technology leader in the biofuels market. The VERBIO share (ISIN DE000A0JL9W6/WKN A0JL9W) has been listed in the prime standard segment of the Frankfurt Stock Exchange since October 2006.
 

Important notice

This publication contains forward-looking statements that are based on assumptions and estimates made by the management of VERBIO Vereinigte BioEnergie AG. Although the Company’s management is of the opinion that these assumptions and estimations are realistic, actual future developments and actual future results may differ significantly from these assumptions and estimates due to a variety of factors. For example, these factors can include changes to the overall economic climate, changes to the legal and regulatory framework in Germany and the EU, and changes in the industry. VERBIO can give no guarantee and accepts no liability as to whether future development and the results actually achieved in future will match the assumptions and estimates made in this publication.


Contact:
VERBIO Vereinigte BioEnergie AG
Ritterstraße 23 (Oelßner's Hof)
04109 Leipzig

Alina Köhler
Investor Relations
Phone: +49(0)341/308530-299
Email: ir@verbio.de/pr@verbio.de


End of Inside Information

27-Apr-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: VERBIO Vereinigte BioEnergie AG
Thura Mark 18
06780 Zörbig
Germany
Phone: +49 (0)341 308530-0
Fax: +49 (0)341 308530-998
E-mail: ir@verbio.de
Internet: www.verbio.de
ISIN: DE000A0JL9W6
WKN: A0JL9W
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1619425

 
End of Announcement EQS News Service

1619425  27-Apr-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1619425&application_name=news&site_id=boersengefluester_html
Visual performance / price development - VERBIO Vereinigte BioEnergie AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.